US Patent 8299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
Patent 8299102 was granted and assigned to Sanofi on October, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
David William Will0
Gerhard Zoller0
Hartmut Strobel0
Paulus Wohlfart0
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals US Patent 8299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
Infobox
Patent Number
082991020
Patent Number
82991020
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082991020
Date of Patent
October 30, 2012
0Patent Application Number
124861180
Date Filed
June 17, 2009
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08299102
Date of patent
October 30, 2012
Patent application number
12486118
Date Filed
June 17, 2009
Patent primary examiner
Find more entities like US Patent 8299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
